Author Correction: Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk

Lue Ping Zhao, Pavitra Roychoudhury, Peter B. Gilbert, Joshua T. Schiffer, Terry P. Lybrand, Thomas H. Payne, April K. Randhawa, Sara E Thiebaud, Margaret G. Mills, Alexander L. Greninger, Chul‐Woo Pyo, Ruihan Wang, Renyu Li, Alexander Thomas, Brandon Norris, Wyatt C. Nelson, Keith R. Jerome, Daniel E. GeraghtyScientific 2022 · DOI · OpenAlex

Introduction

While much of the scientific focus during the COVID-19 pandemic centered on the SARS-CoV-2 "Spike" protein due to its role in cell entry, researchers have increasingly looked toward other functional areas of the viral genome to understand disease severity. This study investigates the genomic evolution of the virus in Washington state, specifically identifying mutations in the nucleocapsid protein and endoRNase that correlate with a higher risk of hospitalization. This document serves as a correction to the original publication in Scientific Reports, ensuring the accurate representation of genomic data visualizations.

Methods and Data

The research utilized a robust dataset of 7,137 viral genomes sourced from GISAID, specifically focusing on sequences collected by laboratories in Washington state. To identify significant genetic variations, the team employed Generalized Linear Models (GLMs) to analyze Single Nucleotide Variations (SNVs). Statistical significance was determined using q-values to account for multiple testing, ensuring that the identified mutations were not merely random occurrences. The study also integrated clinical data to link these genomic signatures with patient hospitalization outcomes.

The analysis revealed significant variability in how the virus evolved across different regions and over time.

Geographic Divergence

By comparing mutational distributions across counties, the researchers found distinct "mutation density" profiles. As shown in the distribution plots, the viral populations in King County and Yakima County exhibited different mutational signatures. This suggests that localized outbreaks can develop unique genetic characteristics, which may influence the clinical severity observed in specific geographic areas.

The Evolutionary Clock

Tracking the virus over a 13-month period (January 2020 to January 2021) showed a steady, nearly linear increase in the logarithmic number of mutations per genome. This highlights the rapid diversification of SARS-CoV-2 during its first year of global circulation.

Distribution and temporal evolution of SARS-CoV-2 mutations in Washington state.

Clinical Significance of Non-Spike Mutations

The most critical finding of this study is the association between specific mutations in the nucleocapsid protein—which packages viral RNA—and endoRNase—involved in replication and immune evasion—with increased hospitalization risk. These results suggest that the virus's internal machinery plays a vital role in its virulence, independent of the Spike protein's entry mechanism. Identifying these "mutational hotspots" allows for better predictive modeling of clinical outcomes based on genomic surveillance.

Conclusion and Future Directions

This research underscores the importance of comprehensive genomic surveillance that looks beyond the Spike protein. While the study provides strong evidence for the role of nucleocapsid and endoRNase mutations in disease severity within Washington state, further research is required to validate these findings in diverse global populations and across newer variants. Understanding the biochemical mechanisms by which these mutations alter the human immune response remains a priority for future work in viral pathogenesis.

Summary updated

BibTeX
@inproceedings{zhao2022author,
  author = {Lue Ping Zhao and Pavitra Roychoudhury and Peter B. Gilbert and Joshua T. Schiffer and Terry P. Lybrand and Thomas H. Payne and April K. Randhawa and Sara E Thiebaud and Margaret G. Mills and Alexander L. Greninger and Chul‐Woo Pyo and Ruihan Wang and Renyu Li and Alexander Thomas and Brandon Norris and Wyatt C. Nelson and Keith R. Jerome and Daniel E. Geraghty},
  title = {{Author Correction: Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk}},
  booktitle = {Scientific},
  year = {2022},
  doi = {10.1038/s41598-022-07002-z},
}
Figure